| Application no. and date | 11705470.0 (espacenet) (Federated) (European Patent Register), 20110124 | | Patent/reg. no. and date | DK/EP 2525834, 20190717 | | Publication date | 20121128 | | Priority no. and date | EP 10151405, 20100122, US 297305 P, 20100122 | | EP pub. no. and date |
EP 2525834 20121128 | | Effective date | | | Applicant/owner | Novo Nordisk Health Care AG,
The Circle 32/38
8058 Zürich-Flughafen, CH | | Applicant ref. no. | P69399DK01 | | Inventor | BUCHARDT, Jens, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
BEHRENS, Carsten, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
JOHANSEN, Nils Langeland, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
ANDERSEN, Henrik Sune, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK,
NÿRSKOV-LAURITSEN, Leif, Novo Nordisk A/S
Novo Allé, 2880 Bagsværd, DK | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 47/54 (2017.01) , A61P 5/00 (2006.01) | | Title | VÆKSTHORMONER MED FORLÆNGET IN-VIVO EFFEKTIVITET | | Int. application no. | EP2011050923 | | Int. publication no. | WO2011089255 | | Related patent (certificate) | CA 2021 00021 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
